RETICULOENDOTHELIAL DYSFUNCTION

This adverse event was reported 10 times

RETICULOENDOTHELIAL DYSFUNCTION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 FLUCYTOSINE 1 0.0007
1 AMPHOTERICIN B LIPOSOME 1 0.0004
2 ITRACONAZOLE 1 0.0001
3 ALEMTUZUMAB 1 0.0001
4 RABEPRAZOLE SODIUM 1 0.0000
5 VORICONAZOLE 1 0.0000
6 METHYLPREDNISOLONE 4 0.0000
7 TACROLIMUS OINTMENT 0.1% 3 0.0000
8 TACROLIMUS EXTENDED-RELEASE CAPSULES 3 0.0000
9 TACROLIMUS 3 0.0000
See all drugs enriched for association with RETICULOENDOTHELIAL DYSFUNCTION